Clinical Trial Update: Feasibility Study on the VERAFEYE System [NA]

View source ↗

Summary

A feasibility study evaluating the VERAFEYE System by LUMA Vision Ltd for atrial septal defect and atrial fibrillation has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Arrhythmia
• Atrial Fibrillation
• Atrial Septal Defect

Drugs mentioned

• VERAFEYE System

Snippet

Sponsor: LUMA Vision Ltd. | Conditions: Atrial Septal Defect, Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2026-02-10